Immatics shares are trading higher after the company announced a $35 million equity investment from Bristol Myers Squibb.
Portfolio Pulse from Benzinga Newsdesk
Immatics has announced a $35 million equity investment from Bristol Myers Squibb, leading to a rise in Immatics' share prices.
July 24, 2023 | 12:35 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Immatics' shares are trading higher after a $35 million equity investment from Bristol Myers Squibb.
The $35 million equity investment from Bristol Myers Squibb is a significant financial boost for Immatics, which is likely to positively impact the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100